Incorrect Packaging Leads To Recall of Birth Control Pill
Incorrect Packaging Leads To Recall of Birth Control Pill

Introduction
On March 4, the FDA advised a nationwide birth control pill recall by Apotex Corp. impacting four lots of Drospirenone and Ethinyl Estradiol tablets, which may have placebo pills in the wrong area or missing tablets.
The recalled birth control pill packs might contain defective blisters with wrong tablet arrangements or empty blister pocket. This might lead the women to take tablets in the wrong order, lowering the effectiveness in preventing pregnancy. The FDA officials warned women need not discontinue taking birth control pills; however, they should follow a non-hormonal method of birth control too, while on the pills. The recall affected packs of tablets with lot numbers, 7DY008A,7DY009A, 7DY010A, and 7DY011A with NDC number 60505-4183-3 on the outer carton. The expiration date is listed as 8/2020.
The pills were manufactured by Oman Pharmaceutical Products, Co. LLC. and distributed by Apotex Corp. According to Apotex, no case of unintended pregnancy was reported.
Latest News
Cencora Directors Settle Opioid Oversight Case for $111M
Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids…
Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients
A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…
FDA Adds New Warnings on Long-Term Opioid Risks
Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.
…